Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORM.L Regulatory News (ORM)

  • There is currently no data for ORM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

21 Jun 2022 07:00

RNS Number : 5559P
Ormonde Mining PLC
21 June 2022
 

21 June 2022

 

Ormonde Mining plc

("Ormonde" or the "Company")

 

Final Results for the Year Ended 31 December 2021

 

Ormonde announces its final results for the year ended 31 December 2021.

 

Key points:

· Newly constructed Board appointed, including Brian Timmons (previously Non-Executive Director) becoming Non-Executive Chairman in October 2021 and Brendan McMorrow becoming Chief Executive Officer in November 2021 - significant ongoing cost savings

· The Board is reviewing a range of acquisition opportunities in appropriate jurisdictions including precious metals, precious stones, battery metals and base metals projects

· Process supported by newly appointed senior technical and geological consultants

· The Board continues to evaluate its strategy to unlock value for shareholders from the Company's existing assets in Spain, including a potential transaction relating to the Company's interests at La Zarza

· Total comprehensive loss of €1.6 million including €0.4 million asset impairment

· Net assets of €5.96 million, including a cash balance of €3.75 million, placing the Company in a position of strength to undertake a transaction

 

Brian Timmons, Chairman, commented:

 

"2021 was a year of transition for the Company as we restructured the Board, reviewed the Company's assets, reorganised the Company to operate on a reduced cost basis, and positioned Ormonde to execute an opportunity to enable the Company to leverage its listing and balance sheet and generate value for shareholders.

 

I would like to thank our shareholders for their continued support and patience. I am conscious that shareholders are keen to see the value of their holding grow. Our job is to ensure that we deliver the best opportunity to achieve this; one which offers the maximum upside from the Company's current balance sheet. I am confident that we have the team in place to execute on that goal and deliver shareholder value."

 

Enquiries:

 

Ormonde Mining plc

Brian Timmons, Non-Executive Chairman

Tel: +353 (0)1 801 4184

 

Vigo Consulting (Investor Relations)

Ben Simons / Charlie Neish

Tel: 44 (0)20 7390 0230

 

Davy (Nomad, Euronext Growth Advisor and Joint Broker)

Barry Murphy

Tel: +353 (0)1 679 6363

 

CHAIRMAN'S REVIEW

 

Introduction

I am pleased to provide my first report to shareholders as Ormonde's Chairman, having been appointed as a Non-Executive Director in June 2020, and subsequently as Non-Executive Chairman in October 2021.

 

2021 was a year of transition for the Company as we restructured the Board, reviewed the Company's assets, reorganised the Company to operate on a reduced cost basis, while building its capability to execute an opportunity that will enable the Company to leverage its listing and balance sheet to generate value for shareholders.

 

Leadership Restructuring

Following the Company's Annual General Meeting in September 2021, Jonathan Henry, and his board and management team left the Company.

 

Brendan McMorrow and Keith O'Donnell joined me on the Board, and Brendan was subsequently appointed in November 2021 to discharge the role of Chief Executive Officer. Brendan, Keith and I each have over 30 years' experience in company management, capital markets, and publicly listed natural resources companies.

 

The Board is now supported in its endeavours by experienced industry consultants. These include Steve Nicol and Professor Garth Earls, who bring with them over 70 years of combined relevant experience. Drawing on his background in mine evaluation and operations, Steve, as Senior Technical and Mining Advisor, is assisting in the evaluation of potential new mining assets. He previously worked with Ormonde to identify and commercialise the Barruecopardo Tungsten mine in Spain, whose 30% interest was sold by the Company in 2020 for €6 million. Garth is assisting the Company as a Senior Geologist, focused on project exploration and development appraisal. Garth has over 40 years of professional experience in mineral exploration, was part of the team that discovered the six-million-ounce Curraghinalt gold deposit in Northern Ireland, and currently serves as Executive Chairman of International Geoscience Services. He is a former Director of the Geological Survey of Northern Ireland and a past Chairman of the Geosciences Committee of the Royal Irish Academy.

 

Steve and Garth provide the complementary skill sets required to evaluate the geological, technical, mining operational and commercial elements of the projects under review and to identify worthwhile opportunities to generate value for the Company and its shareholders.

 

We are now pursuing investment opportunities at a more appropriate and efficient cost to the Company. Until the Company has made material strategic progress in this regard, the directors have waived their entitlement to non-executive directors' fees.

 

New Project Evaluation

The range of opportunities being reviewed include precious metals, precious stones, battery metals and some base metals in a number of jurisdictions including Africa and Europe.

 

Our objective is to invest in a project which will generate meaningful value for shareholders on a sustainable basis. We are reviewing a number of opportunities that appear promising, without presenting excessive risk to shareholders.

 

Existing Projects

Ormonde retains its assets in Spain, namely the Salamanca and Zamora gold projects and the Board continues to evaluate its strategy to unlock value for shareholders from these assets. In addition, the prospect of a transaction relating to the land and data assets of the Company's La Zarza interest continues with discussions with interested parties ongoing.

 

Financials

Ormonde recorded a total comprehensive loss for the period of €1.6 million for 2021, including an asset impairment, noted below, of €0.4 million, compared with a loss of €1.1 million in 2020.

 

Following an internal review of its assets at La Zarza, Ormonde now values its La Zarza interests at €2.0 million, a €0.4 million reduction from previous guidance. The Board considers this to be a fair value and is in discussions regarding a transaction.

 

While reviewing new opportunities, the Board has, since its reconstruction in late 2021, endeavoured to reduce the Company's overheads with Board and management costs lower on a full year basis by approximately 60 percent. The impact of these reductions will be realised in the current year with projected savings related to payroll of c. €0.3 million for 2022 as compared to 2021.

 

As of 31 December 2021, the Company had net assets of €5.96 million, including a cash balance of €3.75 million, placing the Company in a position of considerable strength to undertake a transaction within the natural resources sector.

 

Outlook

On behalf of the Board, I would like to thank our shareholders for their continued support and patience. I am of course conscious that our shareholders are keen to see the value of their holding grow. Our job is to ensure we deliver the best opportunity to achieve this; one which offers the maximum upside from the Company's balance sheet and resources. I am confident that we have the team in place to execute on that goal and deliver value to shareholders. While we are undertaking that process, we will continue to manage costs prudently. I look forward to updating you on the Company's progress in due course.

 

Brian Timmons

Chairman

 

 

Consolidated Statement of Comprehensive Income

for the year ended 31 December 2021

 

 

Year ended

Year ended

31-Dec-21

31-Dec-20

€000s

€000s

 

 

 

 

 

Turnover

0

0

 

 

 

Administration expenses

(1,194)

(1,119)

Impairment of intangibles

(400)

0

 

______

______

Loss on ordinary activities

(1,594)

(1,119)

 

 

 

Finance costs

(24)

(17)

 

______

______

Loss for the year from continuing activities

(1,618)

(1,136)

 

 

 

Profit from discontinued operations

0

1,600

 

______

______

Loss (profit) for the year

(1,618)

464

 

 

 

Taxation

0

0

 

______

______

Loss (profit) for the Period after tax

(1,618)

464

 

 

 

Other comprehensive income

 

 

less: Reclassification of foreign currency gain on disposal of foreign operation

0

(1,600)

 

______

______

Total comprehensive (loss) for the period

(1,618)

(1,136)

 

______

______

 

 

 

Earnings per share

from continuing operations

Basic & diluted (loss) per share (in cent)

(0.34)

(0.24)

Total earnings per share

Basic & diluted (loss) per share (in cent)

(0.34)

0.10

 

 

 

Consolidated Statement of Financial Position

as at 31 December 2021

 

 

31-Dec-21

31-Dec-20

€000s

€000s

Assets

 

Non-current assets

Intangible assets

309

295

 

_______

_______

Total Non-Current Assets

309

295

Current assets

Trade and other receivables

93

58

Asset classified as held for sale

2,000

2,400

Cash & cash equivalents

3,746

4,965

_______

_______

Total Current Assets

5,839

7,423

_______

_______

Total Assets

6,148

7,718

_______

_______

Equity & liabilities

 

 

 

 

Capital and Reserves

 

 

Issued capital

4,725

4,725

Share premium account

29,932

29,932

Share based payment reserve

281

283

Capital conversion reserve fund

29

29

Capital redemption reserve fund

7

7

Retained losses

(29,013)

(27,469)

_______

_______

Equity attributable to the Owners of the Company

5,961

7,507

Current Liabilities

Trade & other payables

187

211

_______

_______

Total Liabilities

187

211

 

_______

_______

Total Equity & Liabilities

6,148

7,718

_______

_______

 

Consolidated Statement of Cashflows

for the year ended 31 December 2021

 

 

Year ended

Year ended

31-Dec-21

31-Dec-20

€000s

€000s

 

 

 

Cashflows from operating activities

 

 

Loss for the year before taxation

 

 

 

 

 

Continuing operations

(1,618)

(1,136)

Discontinued operations

0

1,600

________

________

(1,618)

464

Adjustments for:

Impairment of asset classified as held for sale

400

0

Reclassification of foreign exchange gain

0

(1,600)

Non cash items: Share Option expense

72

19

________

________

 

(1,146)

(1,117)

Movement in Working Capital

Movement in receivables

(35)

320

Movement in liabilities

(24)

(358)

________

________

Net Cash used in operations

(1,206)

(1,155)

 

 

 

Investing activities

 

 

Expenditure on intangible assets

(14)

(10)

Proceeds from disposal of associate

0

6,000

________

________

Net cash (used in)/generated from investing activities

(14)

5,990

 

 

 

Net (decrease)/increase in cash and cash equivalents

(1,219)

4,835

 

 

 

Cash and cash equivalents at the beginning of the year

4,965

130

 

______

______

Cash and cash equivalents at the end of the year

3,746

4,965

 

______

______

 

 

 

Consolidated Statement of Changes in Equity

for the year ended 31 December 2021

 

 

 

 

 

Share based

 

 

 

 

Share

Share

Payment

Other

Retained

 

Capital

Premium

Reserve

Reserves

Losses

Total

 

€000s

€000s

€000s

€000s

€000s

€000s

 

 

Balance at 1 January 2020

13,485

29,932

837

1,636

(37,265)

8,625

 

 

 

 

 

 

 

Loss for the year

-

-

-

-

(1,136)

(1,136)

Reclassification of foreign currency gain on disposal of foreign operation

-

-

-

(1,600)

1,600

0

______

______

______

______

______

______

Total comprehensive income for the year

0

0

0

(1,600)

464

(1,136)

 

 

 

 

 

 

 

Release relating to expired share options

-

-

(572)

-

572

0

Employee share-based compensation

-

-

18

-

-

18

Cancellation of shares

(8,760)

-

-

-

8,760

0

______

______

______

______

______

______

Balance at 31 December 2020

4,725

29,932

283

36

(27,469)

7,507

 

 

 

 

 

 

 

Loss for the year

-

-

-

-

(1,618)

(1,618)

______

______

______

______

______

______

Total comprehensive income for the year

0

0

0

0

(1,618)

(1,618)

 

 

 

 

 

 

 

Release relating to expired share options

-

-

(74)

-

74

0

Employee share-based compensation

-

-

72

-

-

72

______

______

______

______

______

______

Balance at 31 December 2021

4,725

29,932

281

36

(29,013)

5,961

 

______

______

______

______

______

______

 

 

 

1.  The basic loss per share and the diluted loss per share have been calculated on a loss after taxation of €1,618,026 (2020: profit of €464,000) and a weighted average number of Ordinary Shares in issue for the year of 472,507,482 (2020: 472,507,482) for the basic loss per share and 472,507,482 (2020: 472,507,482) for the diluted loss per share.

 

2. The financial information prepared using accounting policies consistent with International Financial Reporting Standards ("IFRS") as adopted by the European Union included in this preliminary statement does not constitute the statutory financial statements for the purposes of Chapter 4 of part 6 of the Companies Act 2014. Full statutory statements for the year ended 31 December 2021 prepared in accordance with IFRS, upon which the auditors have given an unqualified report, have not yet been filed with the Registrar of Companies. Full financial statements for the year ended 31 December 2020 prepared in accordance with IFRS and containing an unqualified report, have been filed with the Registrar of Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR URUARUWUNUUR
Date   Source Headline
5th Sep 20237:00 amRNSTrading on Aquis Growth Market
5th Sep 20237:00 amRNSCancellation - ORMONDE MINING PLC
4th Sep 20238:28 amRNSAdmission to Aquis Growth Market
25th Aug 20233:33 pmRNSResult of EGM & AGM
31st Jul 20236:26 pmRNSNotice of EGM & AGM
27th Jul 20236:19 pmRNSProposed Cancellation of Trading on AIM & Euronext
30th Jun 20236:27 pmRNSInvestment in TRU Precious Metals Corp.
27th Jun 20236:20 pmRNSFinal Results
8th Feb 20236:00 pmRNSOrmonde Mining
7th Feb 20237:30 amRNSSuspension - Ormonde Mining plc
7th Feb 20237:00 amRNSInvestment & Suspension of Listing
13th Jan 20234:40 pmRNSSecond Price Monitoring Extn
13th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Oct 202211:11 amRNSCompletion of Sale of La Zarza Assets
28th Sep 20221:15 pmRNSResult of AGM & EGM
28th Sep 20227:00 amRNSHalf-year Report
30th Aug 20223:24 pmRNSPublication of EGM Circular
29th Jul 20227:00 amRNSSale of La Zarza & Notice of EGM
27th Jun 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
21st Jun 20227:00 amRNSFinal Results
24th Dec 20211:19 pmRNSHolding(s) in Company
30th Nov 20217:00 amRNSAppointment of CEO
19th Nov 20217:00 amRNSGrant of Options
4th Oct 20217:00 amRNSBoard Roles and Disclosures for New Directors
30th Sep 20213:29 pmRNSResult of AGM
23rd Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSAGM Update
14th Jul 20217:00 amRNSAdjourned AGM
1st Jul 20214:40 pmRNSSecond Price Monitoring Extn
1st Jul 20214:35 pmRNSPrice Monitoring Extension
1st Jul 20212:05 pmRNSSecond Price Monitoring Extn
1st Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20219:50 amRNSAGM Update
29th Jun 20217:00 amRNSAGM - Director Requisitions
24th Jun 20214:40 pmRNSSecond Price Monitoring Extn
24th Jun 20214:35 pmRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSAnnual Report & Notice of AGM
26th May 20217:00 amRNSHolding(s) in Company
26th May 20217:00 amRNSFinal Results
7th Apr 20219:05 amRNSSecond Price Monitoring Extn
7th Apr 20219:00 amRNSPrice Monitoring Extension
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20212:43 pmRNSUpdate on Acquisition
23rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
12th Mar 20215:00 pmRNSUpdate on Migration
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.